Lamictal as Add-on Treatment for Bipolar I Disorder in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

301

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Bipolar Disorder
Interventions
DRUG

lamictal

Flexible Dosing

Trial Locations (46)

10549

GSK Investigational Site, Mount Kisco

19104

GSK Investigational Site, Philadelphia

20010

GSK Investigational Site, Washington D.C.

21208

GSK Investigational Site, Baltimore

24013

GSK Investigational Site, Roanoke

27517

GSK Investigational Site, Chapel Hill

30080

GSK Investigational Site, Smyrna

32216

GSK Investigational Site, Jacksonville

32607

GSK Investigational Site, Gainesville

32789

GSK Investigational Site, Winter Park

32839

GSK Investigational Site, Orlando

33613

GSK Investigational Site, Tampa

34201

GSK Investigational Site, Bradenton

36305

GSK Investigational Site, Dothan

43210

GSK Investigational Site, Columbus

43609

GSK Investigational Site, Toledo

44106

GSK Investigational Site, Cleveland

45219

GSK Investigational Site, Cincinnati

45229

GSK Investigational Site, Cincinnati

46202

GSK Investigational Site, Indianapolis

55905

GSK Investigational Site, Rochester

58104

GSK Investigational Site, Fargo

60048

GSK Investigational Site, Libertyville

60563

GSK Investigational Site, Naperville

63304

GSK Investigational Site, Saint Charles

66211

GSK Investigational Site, Overland Park

67206

GSK Investigational Site, Wichita

68526

GSK Investigational Site, Lincoln

71103

GSK Investigational Site, Shreveport

75235

GSK Investigational Site, Dallas

77007

GSK Investigational Site, Houston

77008

GSK Investigational Site, Houston

77030

GSK Investigational Site, Houston

84105

GSK Investigational Site, Salt Lake City

85252

GSK Investigational Site, Scottsdale

87109

GSK Investigational Site, Albuquerque

92108

GSK Investigational Site, San Diego

94304

GSK Investigational Site, Stanford

98033

GSK Investigational Site, Kirkland

98105

GSK Investigational Site, Seattle

02114

GSK Investigational Site, Boston

02115

GSK Investigational Site, Boston

01199

GSK Investigational Site, Springfield

01655

GSK Investigational Site, Worcester

08854

GSK Investigational Site, Piscataway

11794-8790

GSK Investigational Site, Stony Brook

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY